Noble Dip Card (Urine)

Basic Information

• Brand Name: Noble Dip Card (Urine)
• Primary DI: 01085888600657
• Version / Model: NMCard-12-02-BT
• Company Name: NOBLE MEDICAL INC
• Labeler DUNS: 035967806
• Distribution Status: Not in Commercial Distribution
• Device Count in Pkg: 25
• Record Status: Published
• Publish Date: 2022-05-25
• Public Version: 3
• Public Version Date: 2022-10-20
• Public Version Status: Update
• Public Device Record Key: ecfae3b0-b35e-4326-bd60-ef345698f5f8
• Distribution End Date: 2022-05-25

Device Description

AMP500/BAR300/BUP10/BZO300/COC150/MDMA500/MET500/MTD300/OPI300/OXY100/PCP25/THC50

Device Characteristics

• Single Use: Yes
• Prescription Use (Rx): No
• Over the Counter (OTC): No
• Kit: No
• Combination Product: No
• HCT/P: No
• Contains NRL: No
• Not Made with NRL: No
• MRI Safety: Labeling does not contain MRI Safety Information
• Direct Marking Exempt: No
• PM Exempt: No
• Has Serial Number: No
• Has Lot/Batch Number: Yes
• Has Manufacturing Date: No
• Has Expiration Date: Yes
• Has Donation ID: No

Sterilization

• Is Sterile: No
• Sterilization Prior Use: No

Product Codes

Code	Name	Medical Specialty	Regulation #	Device Class
DKZ	Enzyme Immunoassay, Amphetamine	Clinical Toxicology	862.3100	2
DIS	Enzyme Immunoassay, Barbiturate	Clinical Toxicology	862.3150	2
JXM	Enzyme Immunoassay, Benzodiazepine	Clinical Toxicology	862.3170	2
DJG	Enzyme Immunoassay, Opiates	Clinical Toxicology	862.3650	2
DIO	Enzyme Immunoassay, Cocaine And Cocaine Metabolites	Clinical Toxicology	862.3250	2
DJC	Thin Layer Chromatography, Methamphetamine	Clinical Toxicology	862.3610	2
NGG	Test, Methamphetamine, Over The Counter	Clinical Toxicology	862.3610	2
DJR	Enzyme Immunoassay, Methadone	Clinical Toxicology	862.3620	2
LCM	Enzyme Immunoassay, Phencyclidine	Unknown		U
LDJ	Enzyme Immunoassay, Cannabinoids	Clinical Toxicology	862.3870	2

GMDN Terms

Code	Name	Definition	Implantable	Status
46994	Multiple drugs of abuse IVD, kit, rapid ICT, clinical	A collection of reagents and other associated materials intended to be used for the qualitative and/or (semi-)quantitative detection of multiple drugs of abuse in a clinical specimen within a short period, relative to standard laboratory testing procedures, using an immunochromatographic test (ICT) method [lateral flow test]. This is a rapid test used in the laboratory or in point-of-care analyses. It is not intended to be used for self-testing.	No	Active

Identifiers

Type	ID	Issuing Agency	Package Type	Qty per Pkg	Pkg Status	Pkg Discontinue Date
Unit of Use	00858886006650	GS1
Primary	01085888600657	GS1